Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older

• Prif Awduron: Ulrike K. Buchwald (Awdur), Charles P. Andrews (Awdur), John Ervin (Awdur), James T. Peterson (Awdur), Gretchen M. Tamms (Awdur), David Krupa (Awdur), Patrick Ajiboye (Awdur), Lucy Roalfe (Awdur), Andrea L. Krick (Awdur), Tina M. Sterling (Awdur), Meihua Wang (Awdur), Jason C. Martin (Awdur), Jon E. Stek (Awdur), Melvin A. Kohn (Awdur), Temitope Folaranmi (Awdur), Chitrananda Abeygunawardana (Awdur), Jonathan Hartzel (Awdur), Luwy K. Musey (Awdur), the V110-029 Study Group (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Taylor & Francis Group, 2021-08-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

In most countries worldwide, pneumococcal conjugate vaccines have been included in the infant immunization program, resulting in a significant reduction in the burden of pneumococcal disease in children and adults. Shifting serotype distribution due to the indirect effect of infant vaccination with...